A peer-based intervention to educate liver transplant candidates about living donor liver transplantation

2009 ◽  
Vol 16 (1) ◽  
pp. 42-48 ◽  
Author(s):  
Samantha DeLair ◽  
Thomas Hugh Feeley ◽  
Hyunjung Kim ◽  
Juan del Rio Martin ◽  
Leona Kim-Schluger ◽  
...  
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Hany Said Abd Elbaset ◽  
◽  
Ahmad Mohammad Sultan ◽  
Iman Fawzy Montasser ◽  
Hossam E. M. Soliman ◽  
...  

Abstract Background The current SARS-CoV-2 pandemic may negatively impact the care of liver transplant candidates and recipients. Main body of the abstract Accordingly, each country must have its national guidelines based on the current situation and according to available tools. Liver Transplantation Scientific Committee of Waiting List Project in Egypt was established in 13 April 2020. One of the major objectives of this Scientific Committee is the preparation of national protocol for Transplant Centers in Egypt to deal with living donor liver transplantation (LDLT) during SARS-CoV-2 pandemic. Conclusions The protocol highlights basic hospital requirements for LDLT during SARS-CoV-2 pandemic, the patient selection from the waiting list, management of patients on the waiting list, and post-transplant management.


2021 ◽  
pp. 241-258
Author(s):  
Lainie Friedman ◽  
J. Richard Thistlethwaite, Jr

Acute liver failure (ALF), or fulminant hepatic failure, affects approximately two to three thousand patients (adults and children) annually in the United States and accounts for approximately eight percent of all liver transplants. Liver transplant for ALF is complicated by the fact that many patients who present with ALF spontaneously recover; however, the severe time constraints that ALF poses means that patients with ALF are usually listed for deceased donor liver transplant, and potential living donors begin donor evaluations even before it is known whether a transplant will be necessary. ALF was initially a contraindication to living donor liver transplantation (LDLT) both because of poor outcomes and because of concerns that the living donors did not have adequate time to give an informed and voluntary consent. Results have improved and ALF in now an accepted indication for LDLT. This chapter examines the ethical issues raised by LDLT in the setting of ALF.


Sign in / Sign up

Export Citation Format

Share Document